Paul Brinkman Selected Research

Electronic Nose

1/2022	Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
1/2022	Prediction of asthma in early preschool wheezing by electronic nose analysis.
12/2021	Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations.
1/2021	Increased day-to-day fluctuations in exhaled breath profiles after a rhinovirus challenge in asthma.
10/2020	Identification of recent exacerbations in COPD patients by electronic nose.
1/2020	Human volatilome analysis using eNose to assess uncontrolled asthma in a clinical setting.
1/2019	Breathomics and treatable traits for chronic airway diseases.
1/2019	Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma.
1/2018	The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness.
10/2017	Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Brinkman Research Topics

Disease

18	Asthma (Bronchial Asthma) 01/2022 - 06/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 01/2017
4	Inflammation (Inflammations) 01/2020 - 01/2019
2	Respiratory Sounds (Crackle) 01/2022 - 11/2020
2	Pneumonia (Pneumonitis) 01/2022 - 01/2019
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 04/2021
2	Sarcoidosis (Schaumann Disease) 01/2022 - 07/2013
2	Critical Illness (Critically Ill) 04/2019 - 01/2018
2	Malignant Mesothelioma 10/2017 - 03/2012
2	Lung Diseases (Lung Disease) 01/2017 - 01/2015
1	Fibrosis (Cirrhosis) 10/2020
1	Non-alcoholic Fatty Liver Disease 10/2020
1	Eosinophilia 01/2018
1	Altitude Sickness (Mountain Sickness) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Endotoxemia 11/2017
1	Body Weight (Weight, Body) 11/2017
1	Mesothelioma 10/2017
1	Hypersensitivity (Allergy) 01/2017
1	Fever (Fevers) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Airway Remodeling 01/2017
1	Psoriatic Arthritis 01/2016
1	Rheumatoid Arthritis 01/2016
1	Arthritis (Polyarthritis) 01/2016
1	Joint Diseases (Joint Disease) 01/2016
1	Lung Neoplasms (Lung Cancer) 08/2014
1	Pulmonary Sarcoidosis 07/2013
1	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2013

Drug/Important Bio-Agent (IBA)

11	Volatile Organic CompoundsIBA 11/2020 - 01/2017
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 06/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 06/2013
3	SteroidsIBA 01/2019 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2020 - 01/2017
2	Doxycycline (Periostat)FDA LinkGeneric 04/2020 - 01/2017
2	Bronchodilator Agents (Bronchodilators)IBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2020 - 12/2013
2	AsbestosIBA 10/2017 - 03/2012
1	SolutionsIBA 01/2022
1	Chloride Channels (Chloride Channel)IBA 04/2021
1	lumacaftorIBA 04/2021
1	ivacaftorIBA 04/2021
1	dimethyl sulfideIBA 10/2020
1	LimoneneIBA 10/2020
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	mepolizumabIBA 01/2019
1	LipopolysaccharidesIBA 11/2017
1	InterferonsIBA 01/2017
1	GoldIBA 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	Interleukin-13IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	RNA (Ribonucleic Acid)IBA 12/2013

Therapy/Procedure

13	Electronic Nose 01/2022 - 03/2012
6	Therapeutics 01/2022 - 01/2017
1	Biological Therapy 10/2021
1	Precision Medicine 01/2020
1	Extracorporeal Circulation 04/2019
1	Extracorporeal Membrane Oxygenation 04/2019